Global Scientific Director, Discovery Pharmaceutics

Scorpion Therapeutics; Spring House (PA); On-site; USD 180,000 - 240,000; Full time

Job summary

Scorpion Therapeutics seeks a Scientific Director, Discovery Pharmaceutics to lead a global team supporting drug discovery from hit-to-lead to candidate selection within Johnson & Johnson's Innovative Medicine division.

The role emphasizes developability assessments across modalities and strategic oversight of preclinical formulation, characterization, and data analytics, while collaborating across disciplines to influence early design decisions.

Qualifications

• PhD or Master’s with extensive drug discovery experience.
• Proven leadership and talent development abilities.
• Strong knowledge of ADME, preclinical safety, and developability assessments.
• Excellent communication and cross-functional collaboration skills.

Responsibilities

• Provide scientific and strategic leadership on developability assessments for diverse modalities.
• Oversee physical characterization, biopharmaceutical evaluation, and preclinical formulation.
• Develop innovative screening tools and enhance data analytics.
• Influence early compound design for optimized delivery and patient compliance.
• Collaborate across chemistry, biology, PK, and safety teams; manage portfolio deliverables.

Skills

Leadership

ADME knowledge

Developability assessments

Communication

Collaboration

Problem-solving

Digital analytics

Education

PhD in Pharmaceutical Sciences, Chemistry, or related field

Master’s degree with 18+ years experience

Job description

Scorpion Therapeutics seeks a Scientific Director, Discovery Pharmaceutics to lead a global team supporting drug discovery from hit-to-lead to candidate selection within Johnson & Johnson's Innovative Medicine division.

The role emphasizes developability assessments across modalities and strategic oversight of preclinical formulation, characterization, and data analytics, while collaborating across disciplines to influence early design decisions.